Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07816497Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by Centre de Recherches Médicales de Lambaréné. Primary endpoint: Number of participants with Asexual P. falciparum blood stage infection detected by qPCR at 21 days. Started Jul 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07816497.